CHECKPOINT THER. DL-,0001
CHECKPOINT THER. DL-,0001
Share · US1628282063 · CKPT · A3DZZZ (XNCM)
Overview Financial Indicators
3,74 EUR
1,20 % 0,04 EUR
Frankfurt (XNAS) · Current prices and charts at MoneyPeak
29.05.2025 23:37

Current Prices from CHECKPOINT THER. DL-,0001

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
CKPT
USD
29.05.2025 23:37
4,27 USD
4,24 USD
+0,84 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,58 % 0,39 % 1,98 % 64,41 % -5,92 % 114,50 % -80,39 %

Company Profile for CHECKPOINT THER. DL-,0001 Share

Checkpoint Therapeutics, Inc., clinical-stage immunotherapy and targeted oncology company, focuses on the acquisition, development, and commercialization of novel treatments for patients with solid tumor cancers. The company's lead antibody product candidate is Cosibelimab, a fully-human monoclonal antibody of IgG1 subtype that directly binds to programmed death ligand-1 (PD-L1) and blocks the PD-L1 interaction with the programmed death receptor-1 and B7.1 receptors; and CK-302, a human agonistic antibody that is designed to bind to and trigger signaling in GITR expressing cells. It is also developing Olafertinib, a third-generation epidermal growth factor receptor (EGFR) inhibitor, as a treatment for patients with EGFR mutation-positive non-small cell lung cancer; CK-103, a selective and potent small molecule inhibitor of bromodomain and extra-terminal bromodomains; and anti-carbonic anhydrase IX (CAIX) antibody, a fully human preclinical antibody to recognize CAIX expressing cells and kill them via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity. The company has collaboration agreements with TG Therapeutics, Inc. to develop and commercialize certain assets in connection with its licenses in the field of hematological malignancies. The company was incorporated in 2014 and is based in Waltham, Massachusetts. Checkpoint Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.

Company Data

Name CHECKPOINT THER. DL-,0001
Company Checkpoint Therapeutics, Inc.
Symbol CKPT
Website https://www.checkpointtx.com
Primary Exchange XNCM Frankfurt
WKN A3DZZZ
ISIN US1628282063
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Mr. James F. Oliviero III, C.F.A.
Market Capitalization 335 Mio
Country United States of America
Currency EUR
Employees 0,0 T
Address 95 Sawyer Road, 02453 Waltham
IPO Date 2016-12-19

Ticker Symbols

Name Symbol
Frankfurt CZTA.F
NASDAQ CKPT

More Shares

Investors who CHECKPOINT THER. DL-,0001 hold also have the following shares in their portfolio:
LDSBK.SAAR OPF A404
LDSBK.SAAR OPF A404 Bond
RUSSIAN FED. 11-21
RUSSIAN FED. 11-21 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025